Jump to content

Search the hub

Showing results for tags 'Testing'.


More search options

  • Search By Tags

    Start to type the tag you want to use, then select from the list.

  • Search By Author

Content Type


Forums

  • All
    • Commissioning, service provision and innovation in health and care
    • Coronavirus (COVID-19)
    • Culture
    • Improving patient safety
    • Investigations, risk management and legal issues
    • Leadership for patient safety
    • Organisations linked to patient safety (UK and beyond)
    • Patient engagement
    • Patient safety in health and care
    • Patient Safety Learning
    • Professionalising patient safety
    • Research, data and insight
    • Miscellaneous

Categories

  • Commissioning, service provision and innovation in health and care
    • Commissioning and funding patient safety
    • Digital health and care service provision
    • Health records and plans
    • Innovation programmes in health and care
    • Climate change/sustainability
  • Coronavirus (COVID-19)
    • Blogs
    • Data, research and statistics
    • Frontline insights during the pandemic
    • Good practice and useful resources
    • Guidance
    • Mental health
    • Exit strategies
    • Patient recovery
    • Questions around Government governance
  • Culture
    • Bullying and fear
    • Good practice
    • Occupational health and safety
    • Safety culture programmes
    • Second victim
    • Speak Up Guardians
    • Staff safety
    • Whistle blowing
  • Improving patient safety
    • Clinical governance and audits
    • Design for safety
    • Disasters averted/near misses
    • Equipment and facilities
    • Error traps
    • Health inequalities
    • Human factors (improving human performance in care delivery)
    • Improving systems of care
    • Implementation of improvements
    • International development and humanitarian
    • Safety stories
    • Stories from the front line
    • Workforce and resources
  • Investigations, risk management and legal issues
    • Investigations and complaints
    • Risk management and legal issues
  • Leadership for patient safety
    • Business case for patient safety
    • Boards
    • Clinical leadership
    • Exec teams
    • Inquiries
    • International reports
    • National/Governmental
    • Patient Safety Commissioner
    • Quality and safety reports
    • Techniques
    • Other
  • Organisations linked to patient safety (UK and beyond)
    • Government and ALB direction and guidance
    • International patient safety
    • Regulators and their regulations
  • Patient engagement
    • Consent and privacy
    • Harmed care patient pathways/post-incident pathways
    • How to engage for patient safety
    • Keeping patients safe
    • Patient-centred care
    • Patient Safety Partners
    • Patient stories
  • Patient safety in health and care
    • Care settings
    • Conditions
    • Diagnosis
    • High risk areas
    • Learning disabilities
    • Medication
    • Mental health
    • Men's health
    • Patient management
    • Social care
    • Transitions of care
    • Women's health
  • Patient Safety Learning
    • Patient Safety Learning campaigns
    • Patient Safety Learning documents
    • 2-minute Tuesdays
    • Patient Safety Learning Annual Conference 2019
    • Patient Safety Learning Annual Conference 2018
    • Patient Safety Learning Awards 2019
    • Patient Safety Learning Interviews
    • Patient Safety Learning webinars
  • Professionalising patient safety
    • Accreditation for patient safety
    • Competency framework
    • Medical students
    • Patient safety standards
    • Training & education
  • Research, data and insight
    • Data and insight
    • Research
  • Miscellaneous

News

  • News

Find results in...

Find results that contain...


Date Created

  • Start
    End

Last updated

  • Start
    End

Filter by number of...

Joined

  • Start

    End


Group


First name


Last name


Country


Join a private group (if appropriate)


About me


Organisation


Role

Found 194 results
  1. News Article
    Millions of people are being urged to get checks for a condition which has been described as the “silent killer”. If left untreated, high blood pressure can lead to heart attacks, strokes, kidney disease and vascular dementia. Up to 4.2 million people in England are thought to be living with high blood pressure without knowing it – around a third of all those with the condition. Now, a new NHS Get Your Blood Pressure Checked campaign has been launched, backed by health charities, to warn people the condition often has no symptoms. England’s chief medical officer, Professor Sir Chris Whitty, said: “High blood pressure usually has no symptoms but can lead to serious health consequences. “The only way to know if you have high blood pressure is to get a simple, non-invasive blood pressure test. “Even if you are diagnosed, the good news is that it’s usually easily treatable. “Getting your blood pressure checked at a local pharmacy is free, quick and you don’t even need an appointment, so please go for a check today – it could save your life.” Read full story Source: The Independent, 11 March 2024
  2. Content Article
    This consensus statement co-ordinated by the British In Vitro Diagnostics Association (BIVDA) outlines the role of point of care testing in reducing the amount of antibiotics prescribed in primary care. It highlights the issue of antimicrobial resistance (AMR) and outlines evidence for the effectiveness of the rapid point-of-care C-Reactive Protein (POC CRP) test to assist clinical decision making as to whether an individual presenting with symptoms of respiratory tract infection needs an antibiotic. It makes a series of recommendations for the Department of Health and Social Care (DHSC) and NHS England around the use of POC CRP testing in primary care.
  3. News Article
    A test that can detect oesophageal cancer at an earlier stage than current methods should be made more widely available to prevent deaths, charities have said. The capsule sponge test, previously known as Cytosponge, involves a patient swallowing a dissolvable pill on a string. The pill then releases a sponge which collects cells from the oesophagus as it is retrieved. The test can detect abnormalities that form as part of a condition known as Barrett’s oesophagus, which makes a person more likely to develop oesophageal cancer. In the UK 9,300 people are diagnosed with oesophageal cancer a year, according to Cancer Research. The disease is difficult to detect because the symptoms for the cancer are not easily recognisable – and can be mistaken for indigestion – until a it is at an advanced stage. The capsule sponge test can detect the cancer at an earlier stage than the current methods, such as an endoscopy, used to diagnose oesophageal cancer. However, it is only currently available to higher-risk patients as an alternative to endoscopy as part of NHS pilot schemes. Cancer Research UK is working with the National Institute for Health and Care Research (NIHR) on a trial that will recruit 120,000 people to see if the capsule sponge test can reduce deaths from oesophageal cancer. If successful, the test could be rolled out more widely. Mimi McCord, the founder of Heartburn Cancer UK, who lost her husband, Mike, to oesophageal cancer in 2002, said: “Cancer of the oesophagus is a killer that can hide in plain sight. People don’t always realise it, but not all heartburn is harmless. While they keep on treating the symptoms, the underlying cause might be killing them.” Read full story Source: The Guardian, 5 February 2024
  4. News Article
    A blood test for detecting Alzheimer’s disease could be just as accurate as painful and invasive lumbar punctures and could revolutionise diagnosis of the condition, research suggests. Measuring levels of a protein called p-tau217 in the blood could be just as good as lumbar punctures at detecting the signs of Alzheimer’s, and better than a range of other tests under development, experts say. The protein is a marker for biological changes that happen in the brain with Alzheimer’s disease. Dr Richard Oakley, an associate director of research and innovation at the Alzheimer’s Society, said: “This study is a hugely welcome step in the right direction as it shows that blood tests can be just as accurate as more invasive and expensive tests at predicting if someone has features of Alzheimer’s disease in their brain. “Furthermore, it suggests results from these tests could be clear enough to not require further follow-up investigations for some people living with Alzheimer’s disease, which could speed up the diagnosis pathway significantly in future. However, we still need to see more research across different communities to understand how effective these blood tests are across everyone who lives with Alzheimer’s disease.” Read full story Source: The Guardian, 23 January 2024
  5. News Article
    Scientists are hoping a new 45-minute blood test can quickly identify sepsis before it kills. Sepsis is a life-threatening reaction to an infection. It occurs when the body overreacts and starts attacking its own tissues and organs. The hard-to-diagnose condition kills nearly 50,000 Brits a year more than breast, prostate and bowel cancer combined - with severe cases taking just hours to prove fatal. Dr Andrew Retter, an intensive care consultant at Guy’s and St Thomas’ NHS Foundation Trust, who is trialling the test told The Times: “If someone comes into A&E and they’re sick, we can spot that early and start treatment early. “For every hour antibiotics are delayed, people’s mortality goes up by about 7 or 8 per cent if they’ve got sepsis.” Melissa Mead’s one-year-old son William died after weeks of a lingering cough and concerns were dismissed by doctors and 111 operators. The campaigner told The Times: “A test like this at the point of care in A&E, for example, could remove the uncertainty about sepsis, which presents differently in different people. “This could give people a chance at life that my son never had.” Read full story Source: The Independent, 17 December 2023
  6. News Article
    Opt-out blood tests for HIV, Hepatitis B and Hepatitis C will be rolled out to a further 46 hospitals across England, the government has announced. Health Secretary Victoria Atkins said the new £20m programme would lead to earlier diagnoses and treatment. Under the scheme, anyone having a blood test in selected hospital A&E units has also been tested for HIV, Hepatitis B and Hepatitis C, unless they opted out. The trials have been taking place for the last 18 months in 33 hospitals in London, Greater Manchester, Sussex and Blackpool, where prevalence is classed by the NHS as "very high". Figures released by the NHS earlier show those pilots have identified more than 3,500 cases of the three bloodborne infections since April 2022, including more than 580 HIV cases. Ms Atkins said: "The more people we can diagnose, the more chance we have of ending new transmissions of the virus and the stigma wrongly attached to it." She added that rolling out the tests to more hospitals would help ensure early diagnoses so people "can be given the support and the medical treatment they need to live not just longer lives but also higher quality lives". Read full story Source: BBC News, 29 November 2023
  7. Content Article
    Cancer Research UK has set out how the next UK Government could dramatically improve cancer outcomes and prevent 20,000 cancer deaths a year by 2040.  'Longer better lives: A manifesto for cancer research and care' has been developed with the insights of cancer patients and experts from across health, life sciences, government and academic sectors.   The charity said that huge strides have been made in beating cancer – with survival in the UK doubling over the last 50 years.  But it warned that with NHS cancer services in crisis and around half a million new cancer cases each year expected by 2040 – this hard-won progress is at risk of stalling.    With the UK lagging behind comparable countries when it comes to cancer survival, the charity is calling on all political parties to make cancer a top priority in their party manifestos. 
  8. Event
    until
    On the back of the National Point of Care Testing guidance issued in May by the IBMS, RCPath and ACB. This webinar will explore the use case of rapid diagnostic testing to Care, Monitor and Protect. The purpose of a POCT service is to enable the delivery of high quality, accessible diagnostics at the point of need for clinical services, improving clinical outcomes and enhancing the patients’ healthcare experience. The aim should be to ensure that POCT services nationally utilise (and inform) advances in technology to innovate the way in which patients can access diagnostics and clinical services. Technology plays an important part of the patient pathway and in 2022 The World Health Organisation (WHO) published The Target Product Profile (TPP) for readers of rapid diagnostic tests detailing the preferred product characteristics and target regimen profiles. The webinar will provide a guide for commissioners, NHS settings and community pharmacies delivering NHS services. The NHS Long Term Plan highlights the importance of patients receiving care closer to home, shifting from a traditional model of hospital-based services towards a more adaptive community-based approach. Learn about Previous case studies of how Testing to Care, Monitor and Protect has been robustly rolled out across the NHS. Issues faced and how they were overcome. Impact of digital readers when combined with high-quality lateral flow tests in a clinical setting How The Target Product Profile (TPP) for readers of rapid diagnostic tests was developed according to a process based on the WHO Target Product Profiles, Preferred Product Characteristics, and Target Regimen Profiles. Speakers Dr George Newham PhD, Research and Development Manager, SureScreen Diagnostics Dr Rahul Batra, Clinical Innovations and Disruptive Technologies Lead in the Centre for Clinical Infection and Diagnostics Research at Guy’s and St Thomas’ Hospital Julie Hart, NHS Pathway Transformation and Market Access Expert: Diagnostics and Artificial Intelligence Dr Andrew Botham, Chief Scientific Officer - TestCard Register for the webinar
  9. News Article
    Over the counter genetic tests in the UK that assess the risk of cancer or heart problems fail to identify 89% of those in danger of getting killer diseases, a new study has found. Polygenic risk scores are so unreliable that they also wrongly tell one in 20 people who receive them they will develop a major illness, even though they do not go on to do so. That is the conclusion of an in-depth review of the performance of polygenic risk scores, which underpin tests on which consumers spend hundreds of pounds. The findings come amid a boom in the number of companies offering polygenic risk score tests which purport to tell customers how likely they are to get a particular disease. Academics at University College London (UCL) who undertook the research are warning that such tests are so flawed they should be regulated “to protect the public from unrealistic expectations” that they will correctly identify their risk of a particular disease. The authors concluded: “Polygenic risk scores performed poorly in population screening, individual risk prediction and population risk stratification. “Strong claims about the effect of polygenic risk scores on healthcare seem to be disproportionate to their performance.” Read full story Source: The Guardian, 17 October 2023
  10. News Article
    The Biden administration announced Wednesday that it is reviving a programme to mail free rapid coronavirus tests to Americans. Starting 25 September, people can request four free tests per household through covidtests.gov. Officials say the tests are able to detect the latest variants and are intended to be used through the end of the year. The return of the free testing program comes after Americans navigated the latest uptick in covid cases with free testing no longer widely available. The largest insurance companies stopped reimbursing the costs of retail at-home testing once the requirement to do so ended with the public health emergency in May. The Biden administration stopped mailing free tests in June. The Department of Health and Human Services also announced Wednesday that it was awarding $600 million to a dozen coronavirus test manufacturers. Agency officials said the funding would improve domestic manufacturing capacity and provide the federal government with 200 million over-the-counter tests to use in the future. “These critical investments will strengthen our nation’s production levels of domestic at-home COVID-19 rapid tests and help mitigate the spread of the virus,” HHS Secretary Xavier Becerra said in a statement. Experts say free coronavirus testing proved to be an effective public health tool, allowing people to check their status before attending large gatherings or spending time with older or medically vulnerable people at risk of severe disease even after being vaccinated. It also enables people to start antiviral treatments in the early days of infection to prevent severe disease. Read full story (paywalled) Source: Washington Post, 20 September 2023
  11. Content Article
    When it comes to your health, it's easy to fall into the mindset that unless you are having signs or symptoms of an illness, you can put off going to see your doctor and skip yearly exams or tests. But preventative care—such as blood tests, cancer screening, mental health check-ins, vaccinations and tests for genetic conditions—can help keep you from developing a serious illness or having to receive care at the hospital.  Speak Up™ To Prevent Serious Illness is a patient safety campaign from The Joint Commission designed to educate patients on how to find preventative care services, get past barriers and try to avoid reaching a crisis point with their health. The Joint Commission has produced a video, infographic and distribution guide as part of the campaign.
  12. Event
    until
    Public Policy Projects is holding a roundtable "Improving access to genomic testing and medicine for better outcomes and reduced inequalities" on the 20th September from 10:30am to 12pm on Zoom. This session will be chaired by Parker Moss, Chief Commercial & Partnerships Officer at Genomics England, and will seek to explore how genomic technologies can be better utilised, and how services can be appropriately coordinated, to ensure that emerging technology can be used as a tool for reducing inequalities and bettering the overall standard of care for cancer patients in the NHS. The hosts are looking for individuals from Cancer Alliances, ICB, Genomic Laboratory Hubs, Cell Pathology Centres, and Clinical Diagnostic Centres to attend and share their experiences and views at this session. Find out more and register to attend
  13. News Article
    It was hailed as a cutting-edge laboratory that would play a key role in response to Covid-19 and future epidemics, carrying out 300,000 tests a day. Announcing the project in November 2020, then-health secretary Matt Hancock said the project “confirms the UK as a world leader in diagnostics”. But less than 18 months later, the Rosalind Franklin Laboratory – named in honour of the renowned British scientist – has been plagued by failure while costing almost twice as much as its initial £588m budget, The Independent understands. Instead of being at the forefront of the fight against Covid, the project opened six months late, facing a string of issues with equipment, staff and construction, with barely 20% of its touted capacity being reached. Now, as the government winds down its “lighthouse” testing labs as part of the plan to “live with Covid”, leaving the Leamington Spa facility as the last lab standing, there are questions about the future of the site – and whether it would be able to cope with the nation’s testing needs alone if another deadly wave of Covid were to emerge. Read full story Source: The Independent, 28 April 2022
  14. News Article
    A dramatic drop in testing for Covid-19 has left the world blind to the virus’s continuing rampage and its potentially dangerous mutations, the head of the World Health Organization has warned. The UN health agency said that reported Covid cases and deaths had been dropping dramatically. “Last week, just over 15,000 deaths were reported to WHO – the lowest weekly total since March 2020,” WHO chief Tedros Adhanom Ghebreyesus told reporters. While saying this was “a very welcome trend”, he warned that the declining numbers could also be a result of significant cuts in testing for the virus. “As many countries reduce testing, WHO is receiving less and less information about transmission and sequencing,” he said. “This makes us increasingly blind to patterns of transmission and evolution." “When it comes to a deadly virus, ignorance is not bliss.” William Rodriguez, who heads the global diagnostics alliance FIND, also decried that many governments in recent months simply stopped looking for Covid cases. Speaking at the press conference hosted by WHO, he pointed out that in the past four months, amid surging Covid cases from the Omicron variant, “testing rates have plummeted by 70% to 90% worldwide”. The plunging testing rates came despite the fact that there is now more access to accurate testing than ever before. “We have an unprecedented ability to know what is happening,” Rodriguez said. “And yet today, because testing has been the first casualty of a global decision to let down our guard, we’re becoming blind to what is happening with this virus.” Read full story Source: The Guardian, 26 April 2022
  15. News Article
    Pregnant women should be tested for Group B Strep to save the lives of dozens of babies every year, campaigners have warned. Group B Strep is the most recurrent cause of life-threatening illness in newborn babies, with an average of two babies a day identified with the infection. Each week, one of these babies goes on to die while another develops an ongoing long-term disability. More than one in five women carry Group B Strep, a common bacteria that normally causes no harm and no symptoms. However, its presence in the vagina or rectum means babies can be exposed to it during labour and birth. Pregnant women in Britain are not routinely tested for its presence, but a trial led by the University of Nottingham is examining whether such a move would be effective. Campaigners have called for more hospitals to join the pilot to ensure it is successful. Jane Plumb, chief executive of campaign group Group B Strep Support, said: “It’s taken over 20 years of campaigning to get this trial commissioned. It’s devastating that only 30 of the 80 hospitals needed have signed up. We can’t let this trial fail. “We need to fight for the 800 babies per year that are infected with this too-often-deadly infection. We need more hospitals to take part. We need to rally together and get this trial over the finish line.” Ms Plumb said the majority of Group B Strep infections in babies are preventable. “If we don’t know, then they can’t be offered the protective antibiotics in labour,” she said. “Families so often tell us that the first time they hear of Group B Strep is after their baby falls ill. For a mostly preventable infection, this is unforgivable – and must change. “We want to encourage every hospital to take part. We need people to ask for their MP’s support. This is an opportunity to save so many babies’ lives, but we only have six months to get hospitals on board. It really is now or never.” Read full story Source: The Independent, 19 April 2022
  16. News Article
    Patients are being put at risk in the UK because very few sexually transmitted infection (STI) tests offered online meet official standards, experts have warned. The NHS provides free in-person tests for STIs via its network of sexual health and genitourinary medicine clinics. Patients can also order tests via the internet from both NHS-commissioned and private providers, a practice that has become increasingly popular during the pandemic. However, new research in the Sexually Transmitted Infections journal published by the BMJ found that few online STI test services meet national recommended standards, with independent sector providers the least likely to be compliant. Online tests involve the user ordering a kit and either self-sampling by posting the specimen for laboratory analysis, or self-testing by interpreting the test themselves. The research found that the commercial self-sample providers, which advertised to those with symptoms, did not differentiate by STI symptom severity, and eight – seven private and one NHS-commissioned provider – offered no advice on accessing preventive treatment after exposure to HIV as recommended. Self-test providers did not appear to offer any form of order of treatment for patients and five offered tests that were intended for professional use only. The research concluded: “Regulatory change is required to ensure that the standard of care received online meets national guidelines to protect patients and the wider population from the repercussions of underperforming or inappropriate tests." “If we do not act now, patients will continue to receive suboptimal care with potentially significant adverse personal, clinical and public health implications.” Read full story Source: The Guardian, 12 April 2022
  17. News Article
    Overstretched hospitals are stopping routine Covid tests for new patients as “brutal” pressures mount on doctors and nurses, The Independent understands. On Monday there were 1,702 new Covid admissions to hospitals in England as of 9 April – with 16,442 positive patients occupying beds – the NHS leaders warn their ability to tackle the backlog in planned care is at risk. Despite pleas from NHS chiefs to measures such as mask-wearing back into force, ministers said there were no plans to change guidance. The Independent understands at least two major hospitals, in Newcastle and York, have dropped testing of all patients without symptoms in order to alleviate pressure on beds – raising fears that Covid could spread on unchecked wards. Other hospitals are also likely to do the same as bed pressures worsen. Sources have told The Independent some trusts have begun to drop “red” Covid only wards, while some are considering not separating patients in A&E. One expert, critical care doctor Tom Lawton, who analyses hospital-acquired infection data, said that stopping patient testing in hospitals was “worrying” and that the NHS would be putting “blinkers on” just as in-hospital infections were “as high as they’ve ever been”. Read full story Source: The Independent, 11 April 2022
  18. News Article
    Pregnant women with suspected pre-eclampsia will now be offered a test on the NHS to detect the condition. Pre-eclampsia affects some women, usually during the second half of pregnancy or soon after their baby is born. It can lead to serious complications if it is not picked up during maternity appointments, with early signs including high blood pressure and protein in the urine. In some cases, women can develop a severe headache, vision problems such as blurring or flashing, pain just below the ribs, swelling and vomiting. Tests have been available to help rule out the condition but midwives will now use tests designed to pick up a positive diagnosis. In new draft guidance, the National Institute for Health and Care Excellence (NICE) said midwives could use one of four blood tests to help diagnose suspected preterm pre-eclampsia. Jeanette Kusel, the acting director for medtech and digital at NICE, said: “These tests represent a step-change in the management and treatment of pre-eclampsia. New evidence presented to the committee shows that these tests can help successfully diagnose pre-eclampsia, alongside clinical information for decision-making, rather than just rule it out. “This is extremely valuable to doctors and expectant mothers as now they can have increased confidence in their treatment plans and preparing for a safe birth.” Read full story Source: The Guardian, 25 March 2022
  19. News Article
    Lateral flow tests could cost care home visitors £73 a month, a leading UK charity has said, as it renewed calls to keep the devices free in such settings. The government has previously announced that free testing for the general public will end from 1 April, and that this will include care home visitors. However, charities have warned the shift away from free tests could place a heavy financial burden on those visiting care homes, where testing is still advised. James White, the head of public affairs and campaigns at the Alzheimer’s Society, said the proposed charge on lateral flow tests for visitors to care homes was a cruel tax on care. “Over the past two years, we’ve consistently heard many tragic stories from families struggling to visit their loved ones in care homes. For many people with dementia, this isolation has led to a significant deterioration in their condition and mental health,” he said. “With infection rates rising once again, the government must provide free lateral flow tests for all visitors to care homes so that families are not put in an agonising position where they are forced to ration visits, leaving people with dementia once again isolated and alone.” Caroline Abrahams, Age UK’s charity director, said: “No one should have to pay out of their own pocket for tests in circumstances where the expert advice is clear that testing remains an important safeguard against Covid,” she said. “If care home visitors are going to continue to be asked to keep testing to protect their loved ones, it would be completely unacceptable to expect them to pay.” Read full story Source: The Guardian, 15 March 2022 Further reading Visiting restrictions and the impact on patients and their families: a relative's perspective
  20. News Article
    A leading figure in the World Health Organisation Foundation has criticised the UK’s move to dismantle its Covid testing programme as the disease surges in other parts of the world. Mr Anil Soni, chief executive of the WHO Foundation, said in an interview with The Independent that maintaining surveillance over Covid-19 was “incredibly important” and the “dismantling of the testing infrastructure here strikes me as very worrying.” The WHO Foundation chief warned people were “looking the other way” from counties where there is low vaccine coverage to maintain the hope that Covid is over. He warned low vaccine coverage is a “petri dish” for future variants to breed and that the acute phase of the pandemic could not be over until this is addressed. When asked about the UK’s plans to end its NHS Test and Trace programme Mr Soni said: “I’m very concerned about it. “What we’ve seen is, it’s incredibly important to maintain surveillance, and countries in southern Africa should be applauded for detecting Omicron as quickly as they did. Those surveillance systems need to be in place around the world. “We also want to make sure that testing is widely available so that people, when they become infectious, can be aware of their status and keep others safe. For testing not to be available and for us to be moving too quickly to normalcy creates risk.” Mr Soni said the world’s position with Covid was “precarious” and highlighted the surge being seen in Hong Kong, where “health centres are at the verge of collapse, because of how many people are sick”. Read full story Source: The Independent, 10 March 2022
  21. News Article
    A painful infection that mainly affects women is too often dismissed as "women's problems". One in every two women suffer a urinary tract infection (UTI) and they are the second most common infection globally. Among those affected is Hannah Hanratty, 36, who suffered months of agony despite multiple negative tests. During her pregnancy, Mrs Hanratty felt the "razor-blade burning pain" when passing urine. It soon developed into a constant pain. Two weeks after giving birth she needed antibiotics following a routine procedure and said the pain immediately went. "It was a UTI all along that just hadn't been picked up by the tests," she said. Now Dr Emma Hayhurst, a senior lecturer in Molecular Biology at the University of South Wales, has developed a device to improve testing and said the current system is "50 years out of date". At the moment a UTI patient may be asked to provide a urine sample which is sent for analysis, with tests back in two to three days. "That's not good enough, we need to make it quicker," said Dr Hayhurst, explaining that the device she's working on would reduce that. "Within 30 minutes the clinician will be able to say what bacteria is causing the UTI and indeed whether there is a UTI in the first place." Dr Hayhurst has received a £50,000 Women in Innovation Award to further her work, but also in recognition of her position as a female role model in the field of science, technology, engineering and medicine - or STEM subjects, as they're also known. "We should be listening to the women who are telling us this is a problem in their lives, but we know many feel like they are being dismissed," she said. Wales' Health Minister Eluned Morgan is due to publish a quality statement on women's health in the summer, and has announced funding for each health board to have a specialist endometriosis nurse. "I feel I have particular responsibility, as the first woman health minister in a long time, to make sure we look at the issue of women's health in a lot more detail," she said. "There are clearly some gaps, certainly when it comes to research, but also in terms of where people are concentrating their efforts and investment. "Quite often, women are not heard in the same way as men are heard and we've really got to make sure we are rebalancing that unconscious bias." Read full story Source: 7 March 2022
  22. News Article
    Abolishing free Covid tests for those who look after the vulnerable will amount to a “tax on caring” that would cost them more than £500 a year, ministers have been warned. All remaining domestic Covid regulations that restrict public freedoms are ending, with Boris Johnson announing a move away from government intervention to “personal responsibility”. However, the scale of free testing to be retained is still being thrashed out within government. Current data suggests that nearly 4 million people take regular Covid tests, including those who visit and help vulnerable relatives. That number also includes vulnerable people who work in settings that could put them at greater risk, where they have face-to-face contact with others. Research based on the average cost of tests internationally, compiled by the Liberal Democrats, suggests that people who take two tests a week face an average bill of £534 a year. It comes after the government’s own scientific advisers have warned that removing free testing will “increase anxiety” and limit the “social participation outside the home” of those who are clinically vulnerable or who live with someone in that position. “Charging people for the tests they need to safely see vulnerable loved ones is a tax on caring that risks leaving millions of people in lockdown by stealth,” said Ed Davey, the Lib Dem leader. “It means vulnerable people will see fewer loved ones and will be able to enjoy less of their lives. It is unfair and unjust. Ministers need to scrap these plans to stop a ‘cost of living with Covid’ crisis. Throughout the pandemic, people have been trying hard to do the right thing and keep others safe. The government should not be making that harder.” Read full story Source: The Guardian, 19 February 2022
  23. News Article
    Today the Government is expected to announce the end to all Covid restrictions, including ending self-isolation and free testing in the country. However, in an open letter to the UK's Chief Medical Officer and Chief Scientific Officer, the UK science and medical communities say this is a "HUGE mistake". The open letter expresses concern about the Government plans to end testing, surveillance surveys and legal isolation of Covid-19 cases and asks the Government to clarify the scientific advice underpinning these policy decisions as they do not believe there is a solid scientific basis for the policy. "It is almost certain to increase the circulation of the virus and remove the visibility of emerging variants of concern." "The emergence of new variants and a resultant wave of infections can occur very quickly, potentially within just several weeks. The ability to rapidly detect and characterise new variants and to scale up necessary responses (such as TTI and vaccinations) quickly will be very important. Considerations for future response preparedness and surveillance infrastructure should take this into account." "We believe humanity is in a race against the virus." The letter goes on to say that some form of surveillance must be continued to ensure the situation is well understood and new variants of concern identified. Lack of testing is not only detrimental to controlling the spread of SARSCoV2 and detecting new variants, it also puts people who develop Long Covid at a great disadvantage by not having a confirmation of their infection, which is integral to the diagnosis, support and care they need to receive. For the 1 in 4 people in the UK who are clinically vulnerable, the current approach appears a perilous and politicised pandemic response. The authors of the letter are asking members of the UK science and medical communities to sign the open letter. Read the letter in full and sign here
  24. News Article
    GPs should offer all patients presenting with signs of colorectal cancer a faecal immunochemical test (FIT) to reduce the waiting times for a colonoscopy, the National Institute for Health and Care Excellence (NICE) has recommended in draft guidance. The current NICE recommendation is to offer FIT to people presenting to primary care with low risk symptoms suggestive of colorectal cancer, while people with high risk symptoms should be immediately referred to the suspected cancer pathway. However, patients often have lengthy waiting times for colonoscopy because of limited capacity. NICE estimates that the recommendation should lead to 50% fewer referrals for urgent colonoscopies being made by GPs each year. Read full story (paywalled) Source: BMJ, 5 July 2023
  25. News Article
    A digital NHS Health Check is to be rolled out across England from next spring, the government has announced, in an attempt to alleviate the pressure on GP surgeries. The initiative will deliver 1m checks in the first four years, according to the Department for Health and Social Care (DHSC). Tens of thousands of cases of hypertension are expected to be identified and hundreds of strokes and heart attacks prevented. Patients will be able to access the check via a mobile phone, tablet or computer, the DHSC said. Participants will complete an online questionnaire, enter height, weight, and the results of a cholesterol test which they can carry out at home. They will also be asked to have their blood pressure checked at a pharmacy. The results, which will be available online, will direct people to personalised advice. Referrals to GPs will only be made if further tests and treatment are needed. Professor Sir Nilesh Samani, medical director at the British Heart Foundation, said: “This initiative will help to reach more people and encourage them to get their blood pressure and cholesterol levels checked so that, where necessary, healthcare professionals can work with them to manage their condition. “This could play an important role in helping people live healthier for longer and saving lives in the coming years, while reducing pressure on the NHS.” Read full story Source: The Guardian, 28 June 2023
×
×
  • Create New...